How big is the Swiss cannabis market in 2026?

Around CHF 850M total volume (legal + informal). Of which CHF 300M CBD retail, CHF 45M medical, CHF 12M pilot projects, estimated CHF 450–550M informal.

Where do the numbers come from?

Addiction Switzerland (monitoring), FOPH (pilot reports), Swissmedic (medical figures), commercial register and customs data, plus our own price surveys. All sources are linked per indicator in the PDF.

Yes. PDF download free, raw data CSV/JSON under CC-BY 4.0. Attribution appreciated.

How often is it updated?

Annually (Q3), interim updates on relevant events (new pilot city, legal change, market consolidation).

May I cite numbers from the report?

Yes, with mention 'CannabisClub.ch Market Report 2026' and a backlink. Press: press@cannabisclub.ch for quotes and additional data.

Why do your numbers differ from other reports?

We model the informal market more conservatively (consumption data × median use × price) and strictly separate CBD retail from the wellness/cosmetics segment.

Swiss Cannabis Market Report 2026

The most comprehensive independent report on the Swiss cannabis market. Volume, consumption, pilot projects, prices — with cited sources and open-data API.

Key figures 2026

Total market (CBD + THC formal/informal): ~CHF 850M retail revenue 2026.
Regular consumers (30-day): ~220,000 (Addiction Switzerland, FOPH).
CBD segment: ~CHF 300M, growth +8–12% p.a.
Pilot projects: 5 active cities, >4,000 cumulative participants, no documented rise in problem use.
Medical cannabis: +30% p.a. since 2022, ~6,500 patients with prescription.
Black market: estimated CHF 450–550M, price spread vs pilot/club ~60%.

Market volume & segments

The Swiss cannabis market generated approximately CHF 850M in retail revenue in 2026, split across four segments: legal CBD (~CHF 300M), medical cannabis (~CHF 45M), pilot-project sales (~CHF 12M), informal/black market (~CHF 500M, estimated from Addiction Switzerland consumption figures and price sampling).

The CBD segment continues to grow but is consolidating — pure resellers are declining while certified organic producers gain share. The vape category grows disproportionately (+25% p.a.).

CBD retail — CHF 300M (2026) — 55% flower, 25% oil, 10% vape, 10% hash/extracts.
Medical — CHF 45M — 6,500+ prescription patients, +30% p.a.
Pilot projects — CHF 12M — 5 cities, 4,000+ cumulative participants.
Informal — CHF 450–550M — estimated, price spread vs regulated market ~60%.

Consumption & demand

Around 30% of 18–64 year-olds have consumed cannabis at least once (lifetime); ~220,000 are 30-day active consumers (Addiction Switzerland monitoring). For CBD products the user base including wellness/cosmetics is estimated at 500,000–700,000 adults.

Median consumption of active users is 5–8 grams per month. Demand for certified, lab-tested quality is rising: 68% of respondents in a 2025 Addiction Switzerland survey named 'purity/safety' as the main reason for switching away from the black market.

Pilot projects — interim status

Five cities run active FOPH pilot trials: Basel, Zurich, Bern, Lausanne, Geneva (more in preparation). More than 4,000 cumulative participants. Key interim findings: no significant increase in problem consumption, high acceptance of structured points of sale, sharply reduced black-market purchases among participants.

These results provide the empirical basis for a possible federal legal framework in 2027–2028.

Price evolution 2024–2026

Price per gram in the regulated channel (pilot/pharmacy) is CHF 8–12 (standard) resp. CHF 11–15 (premium) in 2026. Black market price sits at CHF 10–14 (standard) resp. CHF 13–18 (premium). Cannabis Social Clubs reach, as a collective purchase, CHF 3–5 per gram for members — the only channel with structurally lower prices.

CBD prices per gram have fallen 12% since 2024 (overproduction, consolidation).

2027 outlook

Base case: legal share of the total market rises from ~40% today to 55–60% by end of 2027, driven by (a) pilot-project expansion, (b) broader medical prescription practice, (c) CBD retail consolidation, (d) growing acceptance of cannabis collectives as a third path alongside pharmacy and pilot.

Risks: cantonal political rollbacks, EU regulatory pressure on Swiss CBD exports, vape safety debate.

Frequently asked — market report

How big is the Swiss cannabis market in 2026?: Around CHF 850M total volume (legal + informal). Of which CHF 300M CBD retail, CHF 45M medical, CHF 12M pilot projects, estimated CHF 450–550M informal.
Where do the numbers come from?: Addiction Switzerland (monitoring), FOPH (pilot reports), Swissmedic (medical figures), commercial register and customs data, plus our own price surveys. All sources are linked per indicator in the PDF.
Is the report free?: Yes. PDF download free, raw data CSV/JSON under CC-BY 4.0. Attribution appreciated.
How often is it updated?: Annually (Q3), interim updates on relevant events (new pilot city, legal change, market consolidation).
May I cite numbers from the report?: Yes, with mention 'CannabisClub.ch Market Report 2026' and a backlink. Press: press@cannabisclub.ch for quotes and additional data.
Why do your numbers differ from other reports?: We model the informal market more conservatively (consumption data × median use × price) and strictly separate CBD retail from the wellness/cosmetics segment.

All figures reflect the state of knowledge as of Q3 2026. Informal-market estimates carry uncertainty. Not medical or legal advice.